OrphanPacific Inc.

OrphanPacific, Inc. is a Japanese pharmaceutical company specializing in the development, manufacturing and distribution of Orphan Drugs. Our mission is to "bring smiles and happiness to patients with rare diseases and their families," and we are committed to tackling the various challenges surrounding rare diseases. By collaborating with pharmaceutical companies and research institutions both domestically and internationally, we strive to deliver new treatments to patients in Japan while also ensuring the stable supply of existing orphan drugs. Our product portfolio focuses on treatments for rare diseases and includes a diverse range of pharmaceuticals aimed at improving patients' quality of life. Our efforts extend to particularly challenging areas within rare diseases, such as ultra-orphan drugs and treatments for pediatric patients. This commitment is rooted in our corporate philosophy of "Leave No One Behind." As a small company with around 50 employees, we each leverage our expertise while expanding our roles and embracing new challenges. Dedicated to pursuing an ethical and sustainable business model, we emphasize our social responsibility. Through collaboration with healthcare professionals and patient organizations, we engage in awareness and information-sharing activities related to rare diseases, ensuring that our initiatives reflect the voices of patients. OrphanPacific continues to create new value at the forefront of rare disease treatment for the benefit of patients.